Conference Proceedings

795MO Pembrolizumab (pembro) in patients (pts) with microsatellite instability-high (MSI-H) advanced endometrial cancer (EC): Updated results from KEYNOTE-158

D O'Malley, GM Bariani, PA Cassier, A Marabelle, AR Hansen, A De Jesus Acosta, WH Miller, T Safra, A Italiano, L Mileshkin, L Xu, F Jin, K Norwood, M Maio

Annals of Oncology | Elsevier BV | Published : 2021

University of Melbourne Researchers